AKZO NOBEL N.V. (AKZA.AS) Fundamental Analysis & Valuation

AMS:AKZA • NL0013267909

52.52 EUR
-1.32 (-2.45%)
Last: Mar 6, 2026, 07:00 PM

This AKZA.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

AKZA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 66 industry peers in the Chemicals industry. AKZA has a medium profitability rating, but doesn't score so well on its financial health evaluation. AKZA may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

5

1. AKZA.AS Profitability Analysis

1.1 Basic Checks

  • In the past year AKZA was profitable.
  • AKZA had a positive operating cash flow in the past year.
  • AKZA had positive earnings in each of the past 5 years.
  • In the past 5 years AKZA always reported a positive cash flow from operatings.
AKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFAKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

1.2 Ratios

  • AKZA's Return On Assets of 4.55% is fine compared to the rest of the industry. AKZA outperforms 65.15% of its industry peers.
  • With a decent Return On Equity value of 13.63%, AKZA is doing good in the industry, outperforming 75.76% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 8.24%, AKZA is doing good in the industry, outperforming 71.21% of the companies in the same industry.
Industry RankSector Rank
ROA 4.55%
ROE 13.63%
ROIC 8.24%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AKZA.AS Yearly ROA, ROE, ROICAKZA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • AKZA's Profit Margin of 6.25% is fine compared to the rest of the industry. AKZA outperforms 66.67% of its industry peers.
  • AKZA's Profit Margin has declined in the last couple of years.
  • The Operating Margin of AKZA (11.46%) is better than 74.24% of its industry peers.
  • In the last couple of years the Operating Margin of AKZA has remained more or less at the same level.
  • AKZA has a Gross Margin (39.86%) which is in line with its industry peers.
  • AKZA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.46%
PM (TTM) 6.25%
GM 39.86%
OM growth 3Y20.63%
OM growth 5Y0.3%
PM growth 3Y24.42%
PM growth 5Y-3.28%
GM growth 3Y3.29%
GM growth 5Y-2.12%
AKZA.AS Yearly Profit, Operating, Gross MarginsAKZA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

3

2. AKZA.AS Health Analysis

2.1 Basic Checks

  • AKZA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • There is no outstanding debt for AKZA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AKZA.AS Yearly Shares OutstandingAKZA.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AKZA.AS Yearly Total Debt VS Total AssetsAKZA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • AKZA has an Altman-Z score of 2.30. This is not the best score and indicates that AKZA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of AKZA (2.30) is comparable to the rest of the industry.
  • The Debt to FCF ratio of AKZA is 8.04, which is on the high side as it means it would take AKZA, 8.04 years of fcf income to pay off all of its debts.
  • AKZA's Debt to FCF ratio of 8.04 is in line compared to the rest of the industry. AKZA outperforms 54.55% of its industry peers.
  • AKZA has a Debt/Equity ratio of 0.79. This is a neutral value indicating AKZA is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.79, AKZA is not doing good in the industry: 69.70% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 8.04
Altman-Z 2.3
ROIC/WACC1.23
WACC6.68%
AKZA.AS Yearly LT Debt VS Equity VS FCFAKZA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.44 indicates that AKZA should not have too much problems paying its short term obligations.
  • AKZA has a Current ratio of 1.44. This is in the lower half of the industry: AKZA underperforms 62.12% of its industry peers.
  • A Quick Ratio of 1.08 indicates that AKZA should not have too much problems paying its short term obligations.
  • AKZA has a Quick ratio (1.08) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.08
AKZA.AS Yearly Current Assets VS Current LiabilitesAKZA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. AKZA.AS Growth Analysis

3.1 Past

  • The earnings per share for AKZA have decreased by -6.43% in the last year.
  • The Earnings Per Share has been decreasing by -1.32% on average over the past years.
  • AKZA shows a decrease in Revenue. In the last year, the revenue decreased by -5.16%.
  • Measured over the past years, AKZA shows a small growth in Revenue. The Revenue has been growing by 3.56% on average per year.
EPS 1Y (TTM)-6.43%
EPS 3Y14.42%
EPS 5Y-1.32%
EPS Q2Q%0%
Revenue 1Y (TTM)-5.16%
Revenue growth 3Y-2.16%
Revenue growth 5Y3.56%
Sales Q2Q%-9.43%

3.2 Future

  • AKZA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.72% yearly.
  • Based on estimates for the next years, AKZA will show a small growth in Revenue. The Revenue will grow by 6.04% on average per year.
EPS Next Y20.5%
EPS Next 2Y14.97%
EPS Next 3Y14.8%
EPS Next 5Y13.72%
Revenue Next Year-2.9%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.93%
Revenue Next 5Y6.04%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AKZA.AS Yearly Revenue VS EstimatesAKZA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
AKZA.AS Yearly EPS VS EstimatesAKZA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

7

4. AKZA.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • AKZA is valuated correctly with a Price/Earnings ratio of 14.43.
  • AKZA's Price/Earnings ratio is rather cheap when compared to the industry. AKZA is cheaper than 80.30% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.29, AKZA is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 11.97, the valuation of AKZA can be described as reasonable.
  • AKZA's Price/Forward Earnings ratio is rather cheap when compared to the industry. AKZA is cheaper than 86.36% of the companies in the same industry.
  • AKZA is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.57, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.43
Fwd PE 11.97
AKZA.AS Price Earnings VS Forward Price EarningsAKZA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AKZA is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
  • 78.79% of the companies in the same industry are more expensive than AKZA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.85
EV/EBITDA 7.68
AKZA.AS Per share dataAKZA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • AKZA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • AKZA's earnings are expected to grow with 14.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.7
PEG (5Y)N/A
EPS Next 2Y14.97%
EPS Next 3Y14.8%

4

5. AKZA.AS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.32%, AKZA has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.21, AKZA pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, AKZA pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.32%

5.2 History

  • The dividend of AKZA decreases each year by -21.52%.
Dividend Growth(5Y)-21.52%
Div Incr Years0
Div Non Decr Years4
AKZA.AS Yearly Dividends per shareAKZA.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • 60.16% of the earnings are spent on dividend by AKZA. This is not a sustainable payout ratio.
DP60.16%
EPS Next 2Y14.97%
EPS Next 3Y14.8%
AKZA.AS Yearly Income VS Free CF VS DividendAKZA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B
AKZA.AS Dividend Payout.AKZA.AS Dividend Payout, showing the Payout Ratio.AKZA.AS Dividend Payout.PayoutRetained Earnings

AKZA.AS Fundamentals: All Metrics, Ratios and Statistics

AKZO NOBEL N.V.

AMS:AKZA (3/6/2026, 7:00:00 PM)

52.52

-1.32 (-2.45%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-03
Earnings (Next)04-21
Inst Owners73.9%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap8.98B
Revenue(TTM)10.16B
Net Income(TTM)635.00M
Analysts76
Price Target69.17 (31.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.32%
Yearly Dividend1.98
Dividend Growth(5Y)-21.52%
DP60.16%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.39%
Min EPS beat(2)-33.37%
Max EPS beat(2)-7.4%
EPS beat(4)0
Avg EPS beat(4)-12.83%
Min EPS beat(4)-33.37%
Max EPS beat(4)-4.18%
EPS beat(8)1
Avg EPS beat(8)-7.59%
EPS beat(12)2
Avg EPS beat(12)-8.15%
EPS beat(16)3
Avg EPS beat(16)-13.47%
Revenue beat(2)0
Avg Revenue beat(2)-2.49%
Min Revenue beat(2)-4.05%
Max Revenue beat(2)-0.93%
Revenue beat(4)0
Avg Revenue beat(4)-3.08%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)-0.93%
Revenue beat(8)1
Avg Revenue beat(8)-1.97%
Revenue beat(12)3
Avg Revenue beat(12)-1.59%
Revenue beat(16)3
Avg Revenue beat(16)-1.66%
PT rev (1m)-1.53%
PT rev (3m)-1.55%
EPS NQ rev (1m)-14.48%
EPS NQ rev (3m)-15.34%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.7%
Revenue NQ rev (1m)-1.04%
Revenue NQ rev (3m)-7.96%
Revenue NY rev (1m)-2.52%
Revenue NY rev (3m)-3.33%
Valuation
Industry RankSector Rank
PE 14.43
Fwd PE 11.97
P/S 0.88
P/FCF 14.85
P/OCF 9.83
P/B 1.93
P/tB 10.43
EV/EBITDA 7.68
EPS(TTM)3.64
EY6.93%
EPS(NY)4.39
Fwd EY8.35%
FCF(TTM)3.54
FCFY6.73%
OCF(TTM)5.34
OCFY10.17%
SpS59.39
BVpS27.24
TBVpS5.03
PEG (NY)0.7
PEG (5Y)N/A
Graham Number47.23
Profitability
Industry RankSector Rank
ROA 4.55%
ROE 13.63%
ROCE 11.94%
ROIC 8.24%
ROICexc 10.26%
ROICexgc 19.94%
OM 11.46%
PM (TTM) 6.25%
GM 39.86%
FCFM 5.96%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y20.63%
OM growth 5Y0.3%
PM growth 3Y24.42%
PM growth 5Y-3.28%
GM growth 3Y3.29%
GM growth 5Y-2.12%
F-Score5
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF 8.04
Debt/EBITDA 2.38
Cap/Depr 81.75%
Cap/Sales 3.04%
Interest Coverage 7.19
Cash Conversion 59.27%
Profit Quality 95.28%
Current Ratio 1.44
Quick Ratio 1.08
Altman-Z 2.3
F-Score5
WACC6.68%
ROIC/WACC1.23
Cap/Depr(3y)81.45%
Cap/Depr(5y)81.15%
Cap/Sales(3y)2.86%
Cap/Sales(5y)2.86%
Profit Quality(3y)116.92%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.43%
EPS 3Y14.42%
EPS 5Y-1.32%
EPS Q2Q%0%
EPS Next Y20.5%
EPS Next 2Y14.97%
EPS Next 3Y14.8%
EPS Next 5Y13.72%
Revenue 1Y (TTM)-5.16%
Revenue growth 3Y-2.16%
Revenue growth 5Y3.56%
Sales Q2Q%-9.43%
Revenue Next Year-2.9%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.93%
Revenue Next 5Y6.04%
EBIT growth 1Y26.94%
EBIT growth 3Y18.02%
EBIT growth 5Y3.86%
EBIT Next Year33.57%
EBIT Next 3Y15.49%
EBIT Next 5Y23.47%
FCF growth 1Y67.13%
FCF growth 3YN/A
FCF growth 5Y-8.8%
OCF growth 1Y36.83%
OCF growth 3Y53.24%
OCF growth 5Y-5.57%

AKZO NOBEL N.V. / AKZA.AS FAQ

What is the ChartMill fundamental rating of AKZO NOBEL N.V. (AKZA.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKZA.AS.


What is the valuation status for AKZA stock?

ChartMill assigns a valuation rating of 7 / 10 to AKZO NOBEL N.V. (AKZA.AS). This can be considered as Undervalued.


What is the profitability of AKZA stock?

AKZO NOBEL N.V. (AKZA.AS) has a profitability rating of 5 / 10.


What is the financial health of AKZO NOBEL N.V. (AKZA.AS) stock?

The financial health rating of AKZO NOBEL N.V. (AKZA.AS) is 3 / 10.


What is the earnings growth outlook for AKZO NOBEL N.V.?

The Earnings per Share (EPS) of AKZO NOBEL N.V. (AKZA.AS) is expected to grow by 20.5% in the next year.